证券记录 · 已归档季度
AXSM
Axsome Therapeutics, Inc. · Healthcare · Biotechnology
15被追踪持有人
+3Δ持有人
4.41M持有股份
$513.88M报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +25.0% ·
股份流向 +13.0% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +8 | 27.61M | $6.75B | +16 | −7 |
| Q1 2026 | 125 | +4 | 27.78M | $4.69B | +9 | −6 |
| Q4 2025 | 120 | +1 | 28.15M | $5.13B | +2 | — |
| Q3 2025 | 19 | 0 | 15.93M | $1.93B | +1 | −2 |
| Q2 2025 | 17 | -1 | 13.98M | $1.46B | — | −1 |
| Q1 2025 | 15 | +3 | 4.41M | $513.88M | +3 | — |
| Q4 2024 | 12 | +1 | 3.90M | $329.80M | +1 | — |
| Q3 2024 | 10 | 0 | 3.50M | $314.34M | — | — |
| Q2 2024 | 10 | — | 4.77M | $384.18M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 934.85K | +2.5% | $109.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 934.85K | +2.5% | $109.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (被动) | 906.02K | -4.3% | $105.67M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 703.28K | +4.5% | $82.02M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 547.66K | +2591.8% | $63.87M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 547.66K | +2591.8% | $63.87M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 13 | Norges Bank ✦ (被动) | 437.50K | +8.6% | $51.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Millennium Management ✦ | 235.31K | +5441.9% | $27.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 134.40K | 新增 | $15.68M | 0.0% | New | 1 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 126.19K | -31.8% | $14.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 83.79K | -83.1% | $9.77M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 83.79K | -83.1% | $9.77M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 68.70K | -46.0% | $8.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 68.70K | -46.0% | $8.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 58.36K | +52.7% | $6.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 58.36K | +52.7% | $6.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 58.36K | +52.7% | $6.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 58.36K | +52.7% | $6.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 58.36K | +52.7% | $6.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 48.00K | -20.0% | $5.60M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 47.01K | 新增 | $5.48M | 0.0% | New | 1 | SEC ↗ |
| 28 | Bridgewater Associates ✦ | 42.83K | 新增 | $4.99M | 0.0% | New | 1 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 31.98K | +2.4% | $3.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $15.68M | 0.0% |
| Two Sigma Investments | $5.48M | 0.0% |
| Bridgewater Associates | $4.99M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 11.40K 股份, $1,926 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据